Sonora Investment Management, LLC - ANTARES PHARMA INC ownership

ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 88 filers reported holding ANTARES PHARMA INC in Q3 2015. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.

Quarter-by-quarter ownership
Sonora Investment Management, LLC ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q3 2021$11,000
-15.4%
3,0000.0%0.00%
-50.0%
Q2 2021$13,000
+8.3%
3,0000.0%0.00%
+100.0%
Q1 2021$12,0000.0%3,0000.0%0.00%0.0%
Q4 2020$12,000
+50.0%
3,0000.0%0.00%0.0%
Q3 2020$8,0000.0%3,0000.0%0.00%0.0%
Q2 2020$8,000
+14.3%
3,0000.0%0.00%0.0%
Q1 2020$7,000
-50.0%
3,0000.0%0.00%0.0%
Q4 2019$14,000
+40.0%
3,0000.0%0.00%0.0%
Q2 2019$10,000
+11.1%
3,0000.0%0.00%0.0%
Q1 2019$9,000
+12.5%
3,0000.0%0.00%0.0%
Q4 2018$8,000
-20.0%
3,0000.0%0.00%0.0%
Q3 2018$10,000
+25.0%
3,0000.0%0.00%0.0%
Q2 2018$8,000
-99.9%
3,0000.0%0.00%0.0%
Q1 2018$6,600,000
+10.6%
3,0000.0%0.00%0.0%
Q4 2017$5,970,000
-38.2%
3,0000.0%0.00%
-50.0%
Q2 2017$9,660,000
+13.4%
3,0000.0%0.00%0.0%
Q1 2017$8,520,000
+21.9%
3,0000.0%0.00%
+100.0%
Q4 2016$6,990,000
+38.7%
3,0000.0%0.00%0.0%
Q3 2016$5,040,000
+60.0%
3,0000.0%0.00%0.0%
Q2 2016$3,150,000
+4.0%
3,0000.0%0.00%0.0%
Q1 2016$3,030,000
+75650.0%
3,0000.0%0.00%0.0%
Q4 2015$4,000
-20.0%
3,0000.0%0.00%
-50.0%
Q3 2015$5,0003,0000.00%
Other shareholders
ANTARES PHARMA INC shareholders Q3 2015
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 3,130,192$12,834,0005.32%
Velan Capital Investment Management LP 1,346,971$5,523,0005.12%
FIRST WILSHIRE SECURITIES MANAGEMENT INC 2,799,953$11,480,0004.03%
Sargent Investment Group, LLC 3,663,275$15,019,0003.78%
PERKINS CAPITAL MANAGEMENT INC 481,483$1,974,0001.62%
Rubric Capital Management LP 10,900,000$44,690,0001.62%
ORACLE INVESTMENT MANAGEMENT INC 1,720,000$7,052,0001.39%
Long Focus Capital Management, LLC 540,000$2,214,0000.28%
OBERWEIS ASSET MANAGEMENT INC/ 344,200$1,411,0000.28%
FIRETHORN WEALTH PARTNERS, LLC 84,069$345,0000.26%
View complete list of ANTARES PHARMA INC shareholders